How beta-catenin expands Foxp3+RORgammat+ Pro-inflammatory T-regulatory cells

β-连环蛋白如何扩增 Foxp3 RORgammat 促炎性 T 调节细胞

基本信息

  • 批准号:
    10203822
  • 负责人:
  • 金额:
    $ 49.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-04-20 至 2022-06-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT The plasticity and functional diversity of regulatory T cells (Tregs) is essential for the maintenance of healthy immunity but it is also exploited in disease. We have described a subset of Tregs that express high levels of β- catenin and promote inflammation. The frequency of these Tregs is increased in inflammatory bowel diseases (and mouse colitis), colon cancer (and mouse polyposis), as well as in multiple sclerosis (and mouse EAE). Expression of a dominant active β-catenin, or ablation of Tcf-1 in Tregs both foster expression of Rorγt the canonical transcription factor of the Th17 lineage, and promote a Th17 differentiation signature. In the mesenteric lymph nodes (MLN) of healthy mice, we identified at least 5 transcriptionally distinct activated clusters of Tregs. One of these clusters is defined by expression of Rorγt and has prominent Th17 differentiation characteristics. In Tcf-1 deficient Tregs the Th17 differentiation profile expanded to all other clusters, and the RORγt cluster increased in frequency. The Tcf-1 deficient Tregs in spite of being more Th17 like, suppressed T-cells, however they failed to suppress inflammation. This indicates a bifurcation of Treg suppressive functions and begs the question, of whether it involves a co-operation between TCF-1 and Foxp3. We have found that, TCF-1 and Foxp3 co-bind enhancer elements of genes involved in T cell activation and Th17 differentiation. β-catenin induces newly accessible chromatin regions at these enhancers and upregulates the expression of the associated genes. Moreover, the E-box binding protein HEB works together with TCF-1 and potentially also Foxp3 to regulate these genes, since Treg specific ablation of both TCF-1 and HEB (but not each one alone) rescues inflammatory and autoimmune pathologies associated with β-catenin activation in Tregs. Consistently, HEB regulates RORγt, represses Foxp3 and peripheral Treg development. Our findings are in line with the notion that FoxP3 directly activates or represses transcription, in a context- and partner-dependent manner. They further implicate β-catenin, TCF-1, and HEB in partnering with Foxp3 to independently regulate the diverse Treg suppressive activities. Based on these findings we hypothesize that, Wnt/β-catenin signaling differentially regulates Treg suppressive functions and diversity, by controlling access of Foxp3 and HEB to select chromatin sites bound by Tcf-1. To address this hypothesis in specific Aim 1 we will determine the role of β-catenin and Tcf-1 in preparing the epigenetic landscape for Foxp3 binding and in shaping Treg cell type diversity. In specific Aim 2 we will determine the role secreted Wnt ligands in defining the functional properties of colon infiltrating Tregs. The proposed studies will elucidate fundamental co- operations/antagonisms between TFs that regulate Treg properties in health, and how microenvironment queues like Wnts exploit them in disease settings. The expected findings have the potential to inform novel diagnostic and therapeutic tools for autoimmunity and cancer.
抽象的 调节性 T 细胞 (Treg) 的可塑性和功能多样性对于维持健康至关重要 免疫力,但它也被用来治疗疾病。我们已经描述了表达高水平 β- 的 Tregs 子集。 连环蛋白并促进炎症。这些 Tregs 的频率在炎症性肠病中增加 (和小鼠结肠炎)、结肠癌(和小鼠息肉病)以及多发性硬化症(和小鼠 EAE)。 Treg 中显性活性 β-catenin 的表达或 Tcf-1 的消除都会促进 Rorγt 的表达 Th17 谱系的经典转录因子,并促进 Th17 分化特征。在 在健康小鼠的肠系膜淋巴结(MLN)中,我们鉴定出至少 5 个转录上不同的激活 Tregs 簇。其中一个簇由 Rorγt 的表达定义,并具有突出的 Th17 差异化特征。在 Tcf-1 缺陷的 Tregs 中,Th17 分化谱扩展到所有其他 簇,并且 RORγt 簇的频率增加。尽管 Th17 较多,但 Tcf-1 缺乏 Tregs 就像抑制 T 细胞一样,但它们未能抑制炎症。这表明 Treg 的分叉 抑制功能并引出了一个问题,即它是否涉及 TCF-1 和 Foxp3 之间的合作。 我们发现,TCF-1 和 Foxp3 共同结合参与 T 细胞激活的基因的增强子元件, Th17分化。 β-连环蛋白在这些增强子处诱导新的可接近染色质区域,并且 上调相关基因的表达。此外,E-box结合蛋白HEB协同作用 TCF-1 和可能还有 Foxp3 来调节这些基因,因为 Treg 特异性消除了 TCF-1 和 Foxp3 HEB(但不是单独的每一种)可挽救与 β-连环蛋白相关的炎症和自身免疫病理 Tregs 中的激活。 HEB 始终调节 RORγt,抑制 Foxp3 和外周 Treg 发育。我们的 研究结果与 FoxP3 在上下文中直接激活或抑制转录的观点一致 依赖伙伴的方式。他们进一步暗示 β-连环蛋白、TCF-1 和 HEB 与 Foxp3 合作, 独立调节不同的 Treg 抑制活动。根据这些发现,我们假设, Wnt/β-catenin 信号传导通过控制 Treg 抑制功能和多样性来差异调节 访问 Foxp3 和 HEB 以选择 Tcf-1 结合的染色质位点。为了具体解决这个假设 目标 1 我们将确定 β-catenin 和 Tcf-1 在准备 Foxp3 结合的表观遗传景观中的作用 以及塑造 Treg 细胞类型多样性。在具体目标 2 中,我们将确定分泌型 Wnt 配体在 定义结肠浸润 Tregs 的功能特性。拟议的研究将阐明基本共同点 调节健康中 Treg 特性的 TF 之间的操作/拮抗作用,以及微环境如何 像 Wnts 这样的队列在疾病环境中利用它们。预期的发现有可能为新颖的研究提供信息 自身免疫和癌症的诊断和治疗工具。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Fotini Gounari其他文献

Fotini Gounari的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Fotini Gounari', 18)}}的其他基金

Tools for reversible short-term degradation of TCF-1 to address its molecular functions
用于 TCF-1 可逆短期降解以解决其分子功能的工具
  • 批准号:
    10647571
  • 财政年份:
    2023
  • 资助金额:
    $ 49.9万
  • 项目类别:
How beta-catenin expands Foxp3+RORgammat+ Pro-inflammatoryT-regulatory cells - Renewal
β-连环蛋白如何扩增 Foxp3 RORgammat 促炎 T 调节细胞 - 更新
  • 批准号:
    10685078
  • 财政年份:
    2022
  • 资助金额:
    $ 49.9万
  • 项目类别:
How beta-catenin expands Foxp3+RORgammat+ Pro-inflammatoryT-regulatory cells - Renewal
β-连环蛋白如何扩增 Foxp3 RORgammat 促炎 T 调节细胞 - 更新
  • 批准号:
    10698144
  • 财政年份:
    2022
  • 资助金额:
    $ 49.9万
  • 项目类别:
Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen
口腔共生结肠癌病原体 Parvimonas micra 致癌的表观遗传机制
  • 批准号:
    10488196
  • 财政年份:
    2021
  • 资助金额:
    $ 49.9万
  • 项目类别:
Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen
口腔共生结肠癌病原体 Parvimonas micra 致癌的表观遗传机制
  • 批准号:
    10296060
  • 财政年份:
    2021
  • 资助金额:
    $ 49.9万
  • 项目类别:
Molecular functions of Tcf-1 in DP thymocytes
DP胸腺细胞中Tcf-1的分子功能
  • 批准号:
    9917226
  • 财政年份:
    2019
  • 资助金额:
    $ 49.9万
  • 项目类别:
Molecular functions of Tcf-1 in DP thymocytes
DP胸腺细胞中Tcf-1的分子功能
  • 批准号:
    10617463
  • 财政年份:
    2019
  • 资助金额:
    $ 49.9万
  • 项目类别:
Molecular functions of Tcf-1 in DP thymocytes
DP胸腺细胞中Tcf-1的分子功能
  • 批准号:
    10061551
  • 财政年份:
    2019
  • 资助金额:
    $ 49.9万
  • 项目类别:
Molecular functions of Tcf-1 in DP thymocytes
DP胸腺细胞中Tcf-1的分子功能
  • 批准号:
    10507783
  • 财政年份:
    2019
  • 资助金额:
    $ 49.9万
  • 项目类别:
Molecular functions of Tcf-1 in DP thymocytes
DP胸腺细胞中Tcf-1的分子功能
  • 批准号:
    10287489
  • 财政年份:
    2019
  • 资助金额:
    $ 49.9万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 49.9万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.9万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 49.9万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.9万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 49.9万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 49.9万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.9万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 49.9万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 49.9万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.9万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了